Centrosomal Protein 85kDa-Like (CEP85L) anticorps (HRP)

Détails pour le produit réf. ABIN1712212, Fournisseur: Connectez-vous pour afficher
Antigène
  • C6orf204
  • NY-BR-15
  • bA57K17.2
  • centrosomal protein 85kDa-like
  • CEP85L
Reactivité
Humain, Souris, Rat (Rattus)
22
16
15
2
2
2
2
2
1
1
Hôte
Lapin
22
Clonalité
Polyclonal
Conjugué
HRP
1
1
1
1
1
1
1
1
1
1
1
1
1
Application
Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Western Blotting (WB)
13
8
6
3
Options
Fournisseur
Connectez-vous pour afficher
Supplier Product No.
Connectez-vous pour afficher
Request

Ce produit gratuit

Envoyez-nous votre proposition de validation. J'aimerais valider ce produit

Savoir plus

Immunogène KLH conjugated synthetic peptide derived from human C6orf204
Isotype IgG
Purification Purified by Protein A.
Autre désignation C6orf204 (CEP85L Antibody Extrait)
Sujet

Making up nearly 6 % of the human genome, chromosome 6 contains around 1,200 genes within 170 million base pairs of sequence. Deletion of a portion of the q arm of chromosome 6 is associated with early onset intestinal cancer suggesting the presence of a cancer susceptibility locus. Porphyria cutanea tarda is associated with chromosome 6 through the HFE gene which, when mutated, predisposes an individual to developing this porphyria. Notably, the PARK2 gene, which is associated with Parkinson's disease, and the genes encoding the major histocompatiblity complex proteins, which are key molecular components of the immune system and determine predisposition to rheumatic diseases, are also located on chromosome 6. Stickler syndrome, 21-hydroxylase deficiency and maple syrup urine disease are also associated with genes on chromosome 6. A bipolar disorder susceptibility locus has been identified on the q arm of chromosome 6. The C6orf204 gene product has been provisionally designated C6orf204 pending further characterization.

Synonyms: bA57K17.2, C6orf204, centrosomal protein 85 kDa-like, CE85L_HUMAN, Coiled-coil domain-containing protein C6orf204, NY-BR-15, RP11-57K17.2, Serologically defined breast cancer antigen NY-BR-15.

ID gène 387119
Indications d'application WB 1:100-1000
IHC-P 1:100-500
Restrictions For Research Use only
Format Liquid
Concentration 1 μg/μL
Buffer Aqueous buffered solution containing 1 % BSA, 50 % glycerol and 0.09 % Gentamicin.
Agent conservateur Gentamicin sulfate
Précaution d'utilisation This product contains Gentamicin sulfate: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Conseil sur la manipulation Do NOT add Sodium Azide! Use of Sodium Azide will inhibit enzyme activity of horseradish peroxidase.
Stock 4 °C
Stockage commentaire Store at 4°C
Date de péremption 12 months